LONGENECKER JOHN P PHD 4
4 · Pacira BioSciences, Inc. · Filed Dec 4, 2019
Insider Transaction Report
Form 4
LONGENECKER JOHN P PHD
Director
Transactions
- Sale
Common Stock
2019-12-02$46.13/sh−1,300$59,972→ 12,761 total - Exercise/Conversion
Stock Option (Right to Buy)
2019-12-02−3,128→ 3,736 totalExercise: $1.61Exp: 2020-09-02→ Common Stock (3,128 underlying) - Exercise/Conversion
Common Stock
2019-12-02$1.61/sh+872$1,404→ 10,933 total - Exercise/Conversion
Common Stock
2019-12-02$1.61/sh+3,128$5,036→ 14,061 total - Exercise/Conversion
Stock Option (Right to Buy)
2019-12-02−872→ 0 totalExercise: $1.61Exp: 2020-09-02→ Common Stock (872 underlying)
Footnotes (2)
- [F1]The option vested as to 25% of the options on September 2, 2011 and vested as to the remaining options in successive equal monthly installments for the subsequent 36 months. The options became exercisable, to the extent vested, from and after the issuer's initial public offering.
- [F2]The option vested as to 75% of the options on September 2, 2010 and vested as to the remaining 25% of the options in successive equal monthly installments for the subsequent 12 months. The options became exercisable, to the extent vested, from and after the issuer's initial public offering.